3 years treating AML
Dr. Arslan’s clinical and research interests center on donor identification, therapy of post-transplant relapse of acute leukemia, treatment of graft versus host disease (GVHD) as well as outcomes of alternative donor transplant. Dr. Arslan is currently the principal investigator for clinical trials including cellular therapy and therapies for GVHD. Dr. Arslan is also participating as co-investigator in several studies involving novel therapies for acute leukemia in upfront and relapsed setting. His research also focuses on treatment of complications from ABO incompatible allogeneic hematopoietic cell transplantation such as pure red cell aplasia.